ArticlePloS one2025
Geographic distribution of inflammatory bowel disease in the UK: A spatially explicit survey.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease (IBD) is characterized by chronic inflammation in the gastrointestinal (GI) tract, with two main forms: Crohn's disease (CD) and ulcerative colitis (UC). While CD can affect any part of the digestive system, UC predominately affects the colon and rectum. The incidence and prevalence rates of IBD cases are increasing worldwide, including in Europe where the UK has one of the highest incidence and prevalence rates. This study reports on a new survey of IBD cases in the UK, involving 5,452 respondents. The survey was promoted periodically by multiple IBD organizations across the UK over 307 days (01 Dec 2021-03 Oct 2022) and collected data on participants' IBD diagnoses and histories. The distributions of CD and UC cases were examined on a grid scale and based on these distributions, relative risk was calculated and mapped in regions where CD and UC cases were recorded. In addition, age- and sex-standardized morbidity rates (ASMRs) for CD and UC were calculated. The results of this UK-wide IBD study reveal an even geographical distribution of reported IBD cases and relative risk across the UK. The ASMR analysis revealed that the reported morbidity rate for women (in the 20-59 age range) was much higher than the morbidity rate for men in both CD and UC cases. In addition, the CD:UC ratio, which has the advantage of normalizing for possible sampling biases, revealed a cluster of large values (i.e., relative risk of CD) in the North-West England which may require further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.